# Debate prop_0635__kimi-k2.6__gpt-5.4-high__s1__tpl_placement_active_20260320f

- topic_id: prop_0635
- proposition: AI model providers should face product-liability-style responsibility for foreseeable harms caused by deployed model behavior when reasonable safeguards were not implemented.
- model_pro: kimi-k2.6
- model_con: gpt-5.4-high
- side_swap: True

## Turn 1: PRO Opening

- model: kimi-k2.6
- raw_words: 301
- clipped_words: 301
- claim_ids: [P1.1], [P1.2], [P1.3], [P1.4], [P1.5], [P1.6], [P1.7]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[P1.1] AI models are products. They are trained, packaged, and monetized at scale. When a product foreseeably injures people because its maker skipped known precautions, product liability exists precisely to force that cost onto the party best able to prevent it—not onto scattered victims.
[P1.2] We do not accept a world where car manufacturers omit brakes because traffic is “emergent,” or where drug makers skip toxicity panels because biology is complex. The proposition before you demands nothing so sweeping as perfection. It asks only that AI providers face liability when they deploy models that cause harms that were foreseeable and could have been prevented by reasonable safeguards: red-teaming, capability evaluations, output filters, basic access controls. These are the brakes of AI deployment.
[P1.3] They are already standard practice at leading labs. When a provider ships without them to shave costs or accelerate release, that omission is a commercial decision, not a force of nature.
[P1.4] Without this liability, harms are ruthlessly externalized. The provider captures the revenue; society absorbs the cost of automated fraud campaigns, nonconsensual synthetic imagery, or discriminatory hiring tools that basic guardrails would have blocked. Current terms of service shields and murky liability carveouts leave injured parties with no recourse and leave providers with weak incentives to invest in safety rather than scale.
[P1.5] Product liability doctrine is built for this market failure. It places the prevention burden on the cheapest cost avoider. The provider alone controls the architecture, the training data, and the deployment gate. Requiring accountability for the omission of feasible, known precautions does not chill innovation; it channels it.
[P1.6] Startups and incumbents alike currently race to deploy faster precisely because the downside risk sits with strangers. Shifting that risk back to the boardroom is how we ensure that speed does not outrun safety.
[P1.7] That is why the motion should pass.

## Turn 2: CON Opening

- model: gpt-5.4-high
- raw_words: 333
- clipped_words: 333
- claim_ids: [C1.1], [C1.2], [C1.3], [C1.4], [C1.5], [C1.6]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C1.1] The motion sounds modest, but on general-purpose AI it is not. “Foreseeable harms” and “reasonable safeguards” are clear standards for products with fixed functions. They are radically unstable for systems that can draft code, tutor students, summarize records, role-play, or be embedded into thousands of downstream tools. Once a model is widely usable, almost any misuse becomes vaguely foreseeable in hindsight. That turns “product-liability-style responsibility” into a standing threat that the provider may answer for whatever a user, integrator, or bad actor later manages to do.
[C1.2] That is the wrong place to put primary responsibility. The actor closest to the harm usually knows the context the model provider does not. A hospital choosing to use AI in triage, a company using it in hiring, a lender using it in underwriting, or a scammer using it for phishing controls the prompts, the workflow, the audience, the review process, and the final decision to act. Those are the points where concrete safeguards matter most.
[C1.3] If you shift liability upstream to the foundation-model provider, you blur causation and let the real deployer say, “the model made me do it,” instead of investing in domain-specific testing, human oversight, authentication, and access controls.
[C1.4] The car-brakes analogy fails for exactly that reason. Brakes are a defined safety device for a defined machine. AI “guardrails” are probabilistic, partial, and often easy to route around. Tighten them and you also block benign uses, reduce utility, and sometimes make models less transparent.
[C1.5] A rule built on hindsight—after harm occurs, every missing filter looks unreasonable—will predictably produce overrestriction, risk-averse design, and a compliance moat that entrenches the largest firms while punishing smaller entrants.
[C1.6] There should be accountability, but it should track control. Punish fraudsters, discriminatory deployers, negligent integrators, and providers who directly market dangerous uses or make concrete misrepresentations. Do not stretch product liability over open-ended model behavior where causation is diffuse, safeguards are contestable, and the most informed decision-maker is often someone else. That is not smart accountability; it is misallocated liability.

## Turn 3: PRO Rebuttal 1

- model: kimi-k2.6
- raw_words: 359
- clipped_words: 340
- claim_ids: [P2.1], [P2.2], [P2.3], [P2.4], [P2.5], [P2.6]
- cited_claim_ids: [C1.1], [C1.2], [C1.4], [C1.5]
- missing_claim_id_refs: (none)

[P2.1] The motion does not ask providers to answer for every imaginable misuse; it asks them to answer for harms that were foreseeable and preventable by reasonable safeguards. CON’s opening inflates that standard into a vague specter of hindsight liability, but product law has long distinguished between remote misuse and predictable injury. A knife maker is not liable for every stabbing, yet may be liable if the blade detaches from the handle because a feasible weld was skipped. When CON warns that “almost any misuse becomes vaguely foreseeable” [C1.1], they are describing a standard no court applies and no serious reading of the motion requires.
[P2.2] Nor does the proposition let downstream actors off the hook. CON argues the deployer knows the context and therefore should bear primary responsibility [C1.2]. That is a false choice. A hospital using a triage tool and the firm that sold it without adequate testing can both be liable; product liability has always operated alongside user responsibility.
[P2.3] The question is who could have prevented the harm most cheaply. The provider controls the weights, the training corpus, and the release decision. Basic red-teaming, output classifiers, and access tiers are not arcane arts; they are architectural choices made at the source. Letting the provider externalize those costs because a scammer later wrote a prompt is not causation; it is moral hazard dressed as diffusion.
[P2.4] CON claims AI guardrails are too probabilistic to analogize to brakes [C1.4], but this is the seatbelt fallacy. No safety device is perfect, and product liability has never demanded perfection—only reasonable precautions. Seatbelts do not save every life; their omission is still negligence. The same holds for deployment filters that block known toxic outputs or capability evaluations that catch dangerous emergent behaviors before release.
[P2.5] The motion explicitly targets omissions, not unavoidable failures.
[P2.6] Finally, the feared compliance moat [C1.5] inverts the economics. The firms already spending on safety are the largest ones; liability would force laggards and cost-cutters to internalize risks they currently dump on the public. A startup unable to afford basic red-teaming should [clipped]

## Turn 4: CON Rebuttal 1

- model: gpt-5.4-high
- raw_words: 347
- clipped_words: 340
- claim_ids: [C2.1], [C2.2], [C2.3], [C2.4], [C2.5], [C2.6], [C2.7]
- cited_claim_ids: [P2.1], [P2.2], [P2.4]
- missing_claim_id_refs: (none)

[C2.1] PRO keeps saying this is only about “foreseeable” harms and “reasonable” safeguards, as if those words solve the problem. They do not. For a general-purpose model, the same capability can be used for tutoring or cheating, customer service or fraud, coding or malware. Once a bad result occurs, it is always easy to say one more filter, one more access gate, one more round of red-teaming was “reasonable.” That is exactly the hindsight problem.
[C2.2] The knife example in [P2.1] fails because a loose handle is a discrete defect. Open-ended language generation is not a loose handle; the alleged harm usually depends on who asked, how they used it, and what they chose to do next.
[C2.3] That is also why “both can be liable” [P2.2] does not rescue the motion. Adding upstream liability still misplaces responsibility. The hospital sets the triage workflow. The employer chooses to rely on a score.
[C2.4] The lender picks variables and thresholds. The scammer sends the message. Those actors know the context, the audience, and the stakes in a way the model provider does not. If you tell all of them that the foundation-model company is the deep pocket for “deployed model behavior,” you blur causation and weaken incentives exactly where the concrete safety decisions are made.
[C2.5] PRO’s “cheapest cost avoider” framing is backwards for many harms. Yes, providers control weights and release, but deployers control authentication, human review, disclosure, logging, escalation, and whether an output is ever acted upon. A hiring firm can cheaply test for disparate impact in its own workflow; a provider cannot cheaply predict every way thousands of firms will embed a general model. The more context-specific the harm, the less plausible it is that the upstream provider is the best preventer.
[C2.6] And the seatbelt analogy [P2.4] still misses the core distinction. Seatbelts are standardized precautions for a defined machine. AI safeguards are probabilistic tradeoffs on a general system. Courts judging after harm will predictably reward overblocking and overrestriction, which protects incumbents and reduces useful, lawful capability.
[C2.7] That is not smart accountability. [clipped]

## Turn 5: PRO Pressure Questions

- model: kimi-k2.6
- raw_words: 74
- clipped_words: 74
- claim_ids: [P3.1], [P3.2]
- cited_claim_ids: [C2.6]
- missing_claim_id_refs: (none)

[P3.1] Q1: If a provider knowingly ships a model capable of generating lethal toxin instructions and skips basic output filters already standard in the industry, do you argue that provider owes no duty to foreseeable victims solely because a downstream user typed the prompt?
[P3.2] Q2: You claim safeguards are uniquely probabilistic [C2.6], yet courts already apply product liability to probabilistic medical devices and complex software. What principled line excludes foundation models from the same standard?

## Turn 6: CON Pressure Questions

- model: gpt-5.4-high
- raw_words: 72
- clipped_words: 72
- claim_ids: [C3.1], [C3.2]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C3.1] Q1: Under your rule, if a hospital, employer, or scammer embeds a general model in a workflow the provider never designed or reviewed, what limiting principle stops the provider from becoming the default deep pocket for all “deployed model behavior”?
[C3.2] Q2: What is your ex ante test for “reasonable safeguards” that avoids hindsight bias—before any incident happens, how would a provider know when enough red-teaming, filtering, and access control has been done?

## Turn 7: PRO Rebuttal 2

- model: kimi-k2.6
- raw_words: 309
- clipped_words: 309
- claim_ids: [P4.1], [P4.2], [P4.3], [P4.4], [P4.5]
- cited_claim_ids: [C2.1], [C2.6]
- missing_claim_id_refs: (none)

[P4.1] A1: The limiting principle is causation and control. Providers face liability only when the harm traces to model behavior that was foreseeable at deployment and preventable by safeguards within their exclusive domain—architecture, training choices, capability evaluations, and baseline output filters—not from arbitrary downstream misuse, user prompts, or context-specific workflow decisions the provider never reviewed. If a hospital designs a reckless triage protocol, the hospital is liable; if a provider ships a model that reliably generates lethal toxin instructions without industry-standard filters, the provider is liable for the baseline defect.
[P4.2] This is the same distribution courts manage daily for complex software and medical devices, and it prevents the provider from becoming a default deep pocket.
[P4.3] A2: The ex ante test is the "reasonable" standard product law already employs: what precautions were technically feasible, customary in the sector, and proportionate to risks revealed by pre-deployment testing? A provider demonstrates compliance through documented capability evaluations, red-teaming against established hazard categories, and access controls matched to demonstrated power. CON's hindsight anxiety [C2.1] is overblown; courts routinely reject after-the-fact wishlists and ask only whether the precaution was genuinely available and proportionate before release. The same juries that handle probabilistic medical devices [C2.6] and complex software can handle this.
[P4.4] CON wants to exempt AI from rules that govern every other complex, multi-actor product. But the provider alone controls the weights, the training corpus, and the release gate. When they skip known safeguards to beat a competitor to market, they externalize the downside onto victims who cannot see inside the black box. Downstream actors can still be liable for their own choices; stripping the provider of baseline accountability does not sharpen incentives elsewhere—it grants impunity to the centralized party best positioned to prevent the harm.
[P4.5] Product liability channels innovation toward safety instead of speed, and the motion requires nothing more. That is why the motion carries.

## Turn 8: CON Rebuttal 2

- model: gpt-5.4-high
- raw_words: 359
- clipped_words: 340
- claim_ids: [C4.1], [C4.2], [C4.3], [C4.4], [C4.5], [C4.6]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C4.1] A1: No. If a provider knowingly releases a model that readily gives lethal toxin instructions and omits an obvious baseline filter, I would not say the user’s prompt alone erases all provider duty. But that helps CON, not PRO: truly narrow, unusually dangerous cases can be handled through negligence, misrepresentation, or targeted regulation without adopting a broad product-liability-style rule for “deployed model behavior” across general-purpose systems.
[C4.2] A2: The principled line is not “probabilistic versus certain.” It is defined product versus open-ended component. Medical devices and most software that fit product liability have a specified function, operating environment, and user context. Foundation models are reconfigurable engines whose outputs depend on prompts, fine-tuning, embedding, and downstream decision rules. Complexity is manageable; indeterminate use and diffuse causation are the problem.
[C4.3] That is why PRO still loses. Their answer to my first question says the limit is provider control over architecture, training, and release. But those are exactly the upstream choices that affect everything the model may later say. In practice, every plaintiff can redescribe a downstream harm as a missing “baseline” filter or capability evaluation.
[C4.4] So the supposed limiting principle does not stop the provider from becoming the default deep pocket; it just labels the whole model stack “exclusive domain” and calls it a defect.
[C4.5] Their answer to my second question is not a real ex ante test either. “Technically feasible, customary, and proportionate” sounds tidy until harm occurs and each term expands after the fact. In a fast-moving field, custom is unsettled, feasibility is contestable, and “proportionate” gets judged by hindsight. That predictably pushes overblocking, defensive design, and compliance-heavy release practices that larger incumbents can absorb far more easily than smaller rivals.
[C4.6] So the round turns on scope. If this were a motion about narrow liability for specifically designed dangerous systems, that would be different. But the proposition sweeps across foreseeable harms from deployed model behavior whenever “reasonable safeguards” were absent. For general-purpose models, that standard is too elastic, too upstream, and too detached from the actors who actually set the [clipped]

## Turn 9: PRO Closing

- model: kimi-k2.6
- raw_words: 175
- clipped_words: 175
- claim_ids: [P5.1], [P5.2]
- cited_claim_ids: [P4.4], [C2.1]
- missing_claim_id_refs: (none)

[P5.1] CON’s entire case rests on treating AI as a unique exception to liability rules that already govern complex, probabilistic products like medical devices and software [P3.2, C4.2]. It is not an exception. The provider alone controls the architecture, training data, and release gate; no downstream hospital, employer, or scammer can retrofit a missing safeguard baked into the weights [P4.4]. When a provider skips feasible, industry-standard precautions to outrun competitors, they capture the revenue while strangers absorb the harm [P1.4, P1.6].
[P5.2] That is precisely the market failure product liability exists to fix, and the motion targets only omissions, not inevitable failures [P1.5, P2.5]. CON’s hindsight anxiety [C2.1] ignores that courts routinely distinguish between remote misuse and omitted baseline precautions that were foreseeable and cheap to implement before release [P2.1, P4.3]. Downstream deployers still answer for their own workflow choices; the motion simply denies providers a unique immunity to ship first and red-team later. Because the law already knows how to place the cost of preventable harm on the party best positioned to prevent it, PRO wins.

## Turn 10: CON Closing

- model: gpt-5.4-high
- raw_words: 199
- clipped_words: 199
- claim_ids: [C5.1], [C5.2], [C5.3]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C5.1] The reason to reject this motion is simple: for general-purpose models, PRO never gave a limiting principle that keeps liability attached to the party who actually controlled the harmful act. Their answer was “architecture, training choices, release gate.” But that describes every downstream case, because every output can be reframed after the fact as a missing baseline filter or insufficient red-teaming. Once that move is allowed, the provider is not liable for a defect; it becomes the default deep pocket for whatever a hospital, employer, lender, or scammer chose to build around the model.
[C5.2] That is not a technicality. It flips incentives. The actor setting the workflow, review process, authentication, thresholds, and final decision gets more room to blame the upstream model, while the provider’s safest legal response is overblocking and compliance-heavy design that large incumbents survive more easily than smaller rivals. Yes, truly narrow, deliberately dangerous releases can be punished.
[C5.3] But this motion is broader than that. It imposes product-liability-style responsibility for “deployed model behavior” whenever a court later decides more safeguards were “reasonable.” For open-ended systems, that standard is too elastic to track real control. When liability no longer follows control, it is bad law. Vote CON.
